Last month, the EPA finalized mercury and air toxic standards for coal- and oil-fired electric utility steam-generating units (EGUs) larger than 25 MW (see IBO 12/31/11). The so-called Utility MACT (maximum achievable control technology) establishes emissions standards for air pollutants, including mercury, arsenic, chromium, nickel and acid gases. One type of instrument for which demand […]
Seeking to solidify its position in the personalized health care market and add to its research instrument business, on January 25, Roche announced a $5.7 billion unsolicited proposal to acquire Illumina (see page 2). The announcement further bolstered expectations surrounding the use of post-Sanger sequencing, especially next-generation sequencing, in clinical and in vitro diagnostic (IVD) […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
